HCW Biologics
HCW Biologics

Dividends • HCW Biologics

HCWB

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI  discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
11/21/2023
11/30/2023
0,077
Monthly
10/23/2023
10/31/2023
0,077
Monthly
9/21/2023
9/29/2023
0,077
Monthly
8/23/2023
8/31/2023
0,077
Monthly
7/21/2023
7/31/2023
0,077
Monthly
6/22/2023
6/30/2023
0,077
Monthly
5/22/2023
5/31/2023
0,077
Monthly
4/20/2023
4/28/2023
0,077
Monthly
3/23/2023
3/31/2023
0,077
Monthly
2/17/2023
2/28/2023
0,077
Monthly
1/20/2023
1/31/2023
0,077
Monthly
12/22/2022
12/30/2022
0,077
Monthly
11/22/2022
11/30/2022
0,077
Monthly
10/21/2022
10/31/2022
0,077
Monthly
9/22/2022
9/30/2022
0,077
Monthly
8/23/2022
8/31/2022
0,077
Monthly
1/2